Physician profile

Robert Herron

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Charleston, WV

NPI 1538402938

$11,143.79

in general payments reported to CMS, 2019-2025

4 companies · $8.80 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$6,000.00
Travel and Lodging$2,005.14
Food and Beverage$529.07
Gift$8.74

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $9,416.79 2022-2025 Da Vinci Surgical System, Ion
Boston Scientific Corporation $1,695.74 2019
Cumberland Pharmaceuticals, INC. $16.99 2022
Ethicon US, LLC $14.27 2023 Echelon Endopath, Echelon; Endopath, Monocryl

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Herron

$11,143.79

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/7230570/robert-herron

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.